vs
Side-by-side financial comparison of ALTERITY THERAPEUTICS LTD (ATHE) and TAKEDA PHARMACEUTICAL CO LTD (TAK). Click either name above to swap in a different company.
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs.
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived th...
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 25 | — | $4.3M | ||
| Q1 24 | — | $4.0M |
| Q2 25 | — | $144.2K | ||
| Q1 24 | — | $317.0K |
| Q2 25 | — | 66.5% | ||
| Q1 24 | — | 69.1% |
| Q2 25 | — | 5.0% | ||
| Q1 24 | — | 12.2% |
| Q2 25 | — | 3.4% | ||
| Q1 24 | — | 7.9% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
